A letter to the Prime Minister: CSHP continues to voice concerns about U.S. plans to import medicines from Canada
CSHP is part of a multi-stakeholder group that continues to have concerns about U.S. plans to import medicines from Canada. It appears the U.S. Administration is proceeding with plans to allow for importation from Canada, and U.S. states are making preparations as well. Canada does not have the drug supply to meet the needs of U.S. patients and is already dealing with significant drug shortages.
On November 6, 2019, CSHP signed a letter, along with other stakeholders, requesting that the government take swift and decisive actions to protect Canada’s drug supply in response to U.S. importation proposals. The signatories urge the government "[...] to prioritize the use of levers to protect Canada’s drug supply from U.S. drug importation plans, and to engage our members whose experience and expertise will contribute to an optimal policy solution for Canadians."